OMC
TAK icon

Old Mission Capital’s Takeda Pharmaceutical TAK Stock Holding History

Old Mission Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,977
Closed -$185K – 1230
2024
Q4 		$185K Buy
13,977
+1,687
+14% +$23.2K ﹤0.01% 858
2024
Q3 		$175K Sell
12,290
-210,768
-94% -$2.99M ﹤0.01% 1129
2024
Q2 		$2.89M Buy
223,058
+124,087
+125% +$1.64M 0.05% 248
2024
Q1 		$1.37M Sell
98,971
-942,555
-90% -$13.7M 0.02% 418
2023
Q4 		$14.9M Buy
1,041,526
+973,935
+1,441% +$13.8M 0.27% 72
2023
Q3 		$1.05M Sell
67,591
-535,934
-89% -$8.3M 0.02% 472
2023
Q2 		$9.48M Buy
603,525
+575,892
+2,084% +$9.44M 0.2% 92
2023
Q1 		$455K Buy
+27,633
New +$440K 0.01% 811
2022
Q4 		– Sell
-57,838
Closed -$750K – 1723
2022
Q3 		$750K Sell
57,838
-177,616
-75% -$2.47M 0.02% 488
2022
Q2 		$3.31M Buy
+235,454
New +$3.36M 0.09% 207
2021
Q2 		– Sell
-81,274
Closed -$1.48M – 1239
2021
Q1 		$1.48M Buy
+81,274
New +$1.46M 0.08% 270
2020
Q4 		– Sell
-169,748
Closed -$3.03M – 673
2020
Q3 		$3.03M Buy
169,748
+79,631
+88% +$1.45M 0.24% 103
2020
Q2 		$1.62M Buy
90,117
+7
+0% +$126 0.12% 137
2020
Q1 		$1.37M Sell
90,110
-19,993
-18% -$362K 0.12% 121
2019
Q4 		$2.17M Sell
110,103
-32,656
-23% -$625K 0.17% 95
2019
Q3 		$2.46M Buy
142,759
+3,490
+3% +$60.4K 0.31% 58
2019
Q2 		$2.46M Sell
139,269
-156,464
-53% -$2.85M 0.31% 66
2019
Q1 		$6.02M Buy
+295,733
New +$5.95M 1.01% 25

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Old Mission Capital's TAK Position: Q1 2025 in Review

Old Mission Capital sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 13,977 shares — an estimated $185K sold.

Old Mission Capital first reported a position in TAK in Q1 2019 and held it in 18 quarters. The position peaked at $14.9M in Q4 2023. 307 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

  • Old Mission Capital reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Old Mission Capital sold 13,977 Takeda Pharmaceutical shares in Q1 2025, an estimated $185K.
  • Old Mission Capital first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 18 quarters.
  • Old Mission Capital's Takeda Pharmaceutical position peaked at $14.9M in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Old Mission Capital's 13F filing for Q1 2025, filed 15 May 2025.